G1GLP1 Note Applies to All countries

HomeGenericsOzempic

GenericAll countries · Checked

Generic Ozempic: Generic Name and Where Generic Semaglutide Is Sold

The generic name of Ozempic is semaglutide. As of November 20, 2026, generic versions have been approved in Canada, India and Brazil, while Novo Nordisk lists the US patent running to 2032.

Is there a generic Ozempic?

In some countries, yes. The generic name is semaglutide, and generics are approved in Canada, India and Brazil.

Generic nameSemaglutide

CanadaApproved April 28, 2026

IndiaLaunched March 21, 2026

BrazilOzivy registered May 26, 2026

Based on Health Canada, Dr. Reddy's and Anvisa announcements and Novo Nordisk's patent table.

What you pay depends a lot on where you live.

See what Ozempic costs in each country

Want the full country list? See generic semaglutide.

Generic nameIs there one?CanadaIndiaBrazilUS and EuropeWhat generic meansWegovyFAQ

Ozempic generic name

The generic name for Ozempic is semaglutide. It is the active ingredient inside the pen.

Ozempic is a brand name. Semaglutide is the medicine. The same ingredient is sold as Wegovy and as Rybelsus tablets.

Ozempic is a once-weekly injection, and the US label lists it for blood sugar control in adults with type 2 diabetes. The weight loss brand is Wegovy.

What the medicine does is covered in Ozempic (semaglutide).

Is there a generic Ozempic?

Yes, but it depends on the country. Some countries have approved generics, and others still have a patent in force.

Generic semaglutide for Ozempic by country

CanadaDr. Reddy's, approved April 28, 2026

IndiaObeda, launched March 21, 2026

BrazilOzivy (EMS), registered May 26, 2026

United StatesPatent to 2032

Japan and EuropePatent to 2031

Patent years are Novo Nordisk's dates for the active ingredient patent, and the Europe figure is based on Germany.

Generic Ozempic in Canada

Health Canada approved Dr. Reddy's generic semaglutide injection on April 28, 2026, the first in the G7.

It is a generic of Ozempic, for adults with type 2 diabetes, given once a week.

When it approved Dr. Reddy's, Health Canada said it was reviewing eight other generic semaglutide submissions. Apotex's Apo-Semaglutide, also a generic of Ozempic, was announced as launched on May 14, 2026. On June 15, 2026, BC PharmaCare listed the Apotex and Dr. Reddy's generics for type 2 diabetes at a 65% discount to Ozempic.

Canadian prices are in Ozempic price Canada, and coverage is in Ozempic savings card Canada.

Generic Ozempic in India

In India, the semaglutide patent ended on March 20, 2026, and generics launched the next day.

Dr. Reddy's launched its version as Obeda on March 21, 2026. It comes in 2 mg and 4 mg pens, and each pen holds at least four weekly doses.

The company price is INR 4,200 per month for both strengths.

Obeda is approved for type 2 diabetes. Other brands and prices are in Ozempic price in India and semaglutide injection price in India.

Generic Ozempic in Brazil

Brazil's regulator Anvisa registered EMS's Ozivy on May 26, 2026, the first synthetic semaglutide pen made as an analog of Ozempic.

Anvisa says the Ozempic patent in Brazil expired on March 20.

Ozivy is for adults with uncontrolled type 2 diabetes. It must be kept in the fridge at 2 to 8°C before and during treatment, which differs from Ozempic.

Anvisa was also reviewing five other synthetic semaglutide products at that time.

Generic Ozempic in the US and Europe

Novo Nordisk lists the Ozempic active ingredient patent as running to 2032 in the US and to 2031 in Japan and Europe.

So in those places you use the brand product today. What a generic would cost is not known yet.

US prices are in Ozempic cost in the US, and the manufacturer offer is in Ozempic coupon and copay card. UK prices are in Ozempic cost UK.

What a generic Ozempic is

A generic is approved as the same as the brand: the same ingredient, strength and way of giving it. The name and the maker differ.

The pen and the storage rules can still differ by product, as Ozivy shows. Read the leaflet that comes with your own pen.

Switching to a generic, or changing your dose, is a decision for your prescriber. Dose steps for the brand are in Ozempic dosage chart.

Generic Wegovy

Wegovy is the same semaglutide sold for weight loss, and its generic situation is covered separately in Wegovy generic name.

Tirzepatide, the ingredient in Mounjaro, is a different drug. See Mounjaro generic name.

The wider picture is in generic GLP-1 drugs.

Ozempic generic FAQ

What is the generic name for Ozempic?

Semaglutide. Wegovy and Rybelsus contain it too.

Can I get generic Ozempic?

In Canada, India and Brazil, generics are approved. In the US, Japan and Europe the patents run to 2032 or 2031, so the brand is the product to ask for.

How much is generic Ozempic?

In India, Dr. Reddy's says INR 4,200 per month. For other countries, use the price pages above.

Is generic Ozempic approved for weight loss?

No. The Canadian product, Obeda in India and Ozivy in Brazil were all announced for type 2 diabetes.

When does the Ozempic patent end?

It ended on March 20, 2026 in India and Brazil. Novo Nordisk lists 2031 for Japan and Europe and 2032 for the US.

Keep reading

Ozempic price by country

Generic semaglutide

Ozempic dosage chart

Ozempic price in India

Ozempic price Canada

This page follows regulator and company announcements and is updated when the status changes. See how we check our pages.

Update log

: First published.

Sources

Canada becomes the first G7 country to approve a generic version of semaglutide (Health Canada, April 28, 2026).

Notice of Compliance information (Health Canada).

Dr. Reddy's launch of Obeda in India (press release, March 21, 2026).

Anvisa approves the first synthetic semaglutide pen for diabetes (Anvisa, Brazil, May 27, 2026).

Patent status for products with marketing authorisation (Novo Nordisk Annual Report 2025).

Ozempic US prescribing information (FDA).

GLP1 Note is an independent information site. Your own treatment is decided by your prescriber.